Jakub JW - Search Results

1

In-transit melanoma: an individualized approach.

Grotz TE, Mansfield AS, Kottschade LA, Erickson LA, Otley CC, Markovic SN, Jakub JW. Grotz TE, et al. Among authors: jakub jw. Oncology (Williston Park). 2011 Dec;25(14):1340-8. Oncology (Williston Park). 2011. PMID: 22329185 Free article.

2

Metastatic malignant melanoma.

Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR; Melanoma Study Group of the Mayo Clinic Cancer Center. Markovic SN, et al. Among authors: jakub jw. G Ital Dermatol Venereol. 2009 Feb;144(1):1-26. G Ital Dermatol Venereol. 2009. PMID: 19218908 Review.

3

The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.

Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, Reintgen DS. Jakub JW, et al. Ann Surg Oncol. 2009 Aug;16(8):2245-51. doi: 10.1245/s10434-009-0530-5. Epub 2009 Jun 11. Ann Surg Oncol. 2009. PMID: 19517194

4

Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis.

Mansfield AS, Holtan SG, Grotz TE, Allred JB, Jakub JW, Erickson LA, Markovic SN. Mansfield AS, et al. Among authors: jakub jw. Mod Pathol. 2011 Apr;24(4):487-94. doi: 10.1038/modpathol.2010.227. Epub 2010 Dec 10. Mod Pathol. 2011. PMID: 21151098 Free article.

5

Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma.

Grotz TE, Markovic SN, Erickson LA, Harmsen WS, Huebner M, Farley DR, Pockaj BA, Donohue JH, Sim FH, Grant CS, Bagaria SP, Shives TC, Balch CM, Jakub JW; Mayo Clinic. Grotz TE, et al. Among authors: jakub jw. Mayo Clin Proc. 2011 Jun;86(6):522-8. doi: 10.4065/mcp.2011.0059. Mayo Clin Proc. 2011. PMID: 21628616 Free PMC article.

6

Regional lymphatic immunity in melanoma.

Grotz TE, Mansfield AS, Jakub JW, Markovic SN. Grotz TE, et al. Among authors: jakub jw. Melanoma Res. 2012 Feb;22(1):9-18. doi: 10.1097/CMR.0b013e32834e1f33. Melanoma Res. 2012. PMID: 22082957 Review.

7

Natural history of merkel cell carcinoma following locoregional recurrence.

Grotz TE, Tarantola TI, Otley CC, Weaver AL, McGree ME, Jakub JW. Grotz TE, et al. Among authors: jakub jw. Ann Surg Oncol. 2012 Aug;19(8):2556-62. doi: 10.1245/s10434-011-2161-x. Epub 2012 Mar 28. Ann Surg Oncol. 2012. PMID: 22453243

8

Minimally invasive inguinal lymph node dissection (MILND) for melanoma: experience from two academic centers.

Abbott AM, Grotz TE, Rueth NM, Hernandez Irizarry RC, Tuttle TM, Jakub JW. Abbott AM, et al. Among authors: jakub jw. Ann Surg Oncol. 2013 Jan;20(1):340-5. doi: 10.1245/s10434-012-2545-6. Epub 2012 Aug 9. Ann Surg Oncol. 2013. PMID: 22875645 Clinical Trial.

9

Prognostic factors in Merkel cell carcinoma: analysis of 240 cases.

Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Grotz TE, Jakub JW, Roenigk RK, Brewer JD, Weaver AL, Otley CC. Tarantola TI, et al. Among authors: jakub jw. J Am Acad Dermatol. 2013 Mar;68(3):425-32. doi: 10.1016/j.jaad.2012.09.036. Epub 2012 Nov 27. J Am Acad Dermatol. 2013. PMID: 23200197

10

Preservation of the deep muscular fascia and locoregional control in melanoma.

Grotz TE, Glorioso JM, Pockaj BA, Harmsen WS, Jakub JW. Grotz TE, et al. Among authors: jakub jw. Surgery. 2013 Apr;153(4):535-41. doi: 10.1016/j.surg.2012.09.009. Epub 2012 Dec 4. Surgery. 2013. PMID: 23218886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters